Skip to main content
Top
Published in: International Journal of Pediatric Endocrinology 1/2012

Open Access 01-12-2012 | Research

Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome

Authors: Nouhad Raissouni, Andrey Kolesnikov, Radhika Purushothaman, Sunil Sinha, Sonal Bhandari, Amrit Bhangoo, Shahid Malik, Revi Mathew, Jean-Patrice Baillargeon, Maria Isabel Hernandez, Michael Rosenbaum, Svetlana Ten, David Geller

Published in: International Journal of Pediatric Endocrinology | Issue 1/2012

Login to get access

Abstract

Background

First-degree relatives (FDRs) of women with PCOS are at increased risk for impaired insulin sensitivity and diabetes mellitus. Glucose tolerant FDR have evidence of insulin resistance and hyperinsulinemia prior to emergence of frank PCOS.

Aim

To study insulin dynamics parameters in the early adolescent FDR of women with PCOS.

Methods

This is a cross-sectional study involving 18 adolescents whose mothers or sisters had been diagnosed with PCOS and 21 healthy, age-matched control adolescents without FDR. Subjects underwent anthropometric measurements, steroid profiling and frequently sampled Intravenous Glucose Tolerance Test (IVGTT), Homeostasis Model Assessment (HOMA) index, Glucose Disposal Index (GDI), Acute Insulin Response (AIR) and Quantitative insulin sensitivity check index (QUICKI) were derived from IVGTT results.

Results

FDRs showed significantly higher mean HOMA and lower GDI. There were no differences in mean age or BMI Z-score between the cohorts. No differences in sex steroids or AIR were identified between groups.

Conclusion

Female adolescent FDR of women with PCOS have higher HOMA index and lower QUICKI, reflecting altered insulin sensitivity and lower GDI reflecting poorer beta-cell function. The presence of multiple risk factors for type 2 diabetes suggests that aggressive screening of the early adolescent FDR of women with PCOS is indicated.
Literature
1.
go back to reference Asuncion M: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metabol. 2000, 85 (7): 2434-2438. 10.1210/jc.85.7.2434. Asuncion M: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metabol. 2000, 85 (7): 2434-2438. 10.1210/jc.85.7.2434.
2.
go back to reference Diamanti-Kandarakis E: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metabol. 1999, 84 (11): 4006-4011. 10.1210/jc.84.11.4006.CrossRef Diamanti-Kandarakis E: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metabol. 1999, 84 (11): 4006-4011. 10.1210/jc.84.11.4006.CrossRef
3.
go back to reference Azziz R: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metabol. 2004, 89 (6): 2745-2749. 10.1210/jc.2003-032046.CrossRef Azziz R: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metabol. 2004, 89 (6): 2745-2749. 10.1210/jc.2003-032046.CrossRef
4.
go back to reference Franks S, Stark J, Hardy K: Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008, 14 (4): 367-378. 10.1093/humupd/dmn015.CrossRefPubMed Franks S, Stark J, Hardy K: Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008, 14 (4): 367-378. 10.1093/humupd/dmn015.CrossRefPubMed
5.
go back to reference Gilling-Smith C: Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metabol. 1994, 79 (4): 1158-1165. 10.1210/jc.79.4.1158. Gilling-Smith C: Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metabol. 1994, 79 (4): 1158-1165. 10.1210/jc.79.4.1158.
6.
go back to reference Ibanez L, Potau N, Carrascosa A: Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS). Trends Endocrinol Metab. 1998, 9 (2): 72-77. 10.1016/S1043-2760(98)00014-9.CrossRefPubMed Ibanez L, Potau N, Carrascosa A: Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS). Trends Endocrinol Metab. 1998, 9 (2): 72-77. 10.1016/S1043-2760(98)00014-9.CrossRefPubMed
7.
go back to reference Ehrmann DA: Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995, 96 (1): 520-527. 10.1172/JCI118064.PubMedCentralCrossRefPubMed Ehrmann DA: Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995, 96 (1): 520-527. 10.1172/JCI118064.PubMedCentralCrossRefPubMed
8.
go back to reference Holte J: Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab. 1996, 10 (2): 221-247. 10.1016/S0950-351X(96)80085-1.CrossRefPubMed Holte J: Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab. 1996, 10 (2): 221-247. 10.1016/S0950-351X(96)80085-1.CrossRefPubMed
9.
go back to reference Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18 (6): 774-800. 10.1210/er.18.6.774.PubMed Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18 (6): 774-800. 10.1210/er.18.6.774.PubMed
10.
go back to reference Dunaif A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989, 38 (9): 1165-1174. 10.2337/diabetes.38.9.1165.CrossRefPubMed Dunaif A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989, 38 (9): 1165-1174. 10.2337/diabetes.38.9.1165.CrossRefPubMed
11.
go back to reference Ehrmann DA: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999, 22 (1): 141-146. 10.2337/diacare.22.1.141.CrossRefPubMed Ehrmann DA: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999, 22 (1): 141-146. 10.2337/diacare.22.1.141.CrossRefPubMed
12.
go back to reference Legro RS: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metabol. 1999, 84 (1): 165-169. 10.1210/jc.84.1.165. Legro RS: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metabol. 1999, 84 (1): 165-169. 10.1210/jc.84.1.165.
13.
go back to reference Dahlgren E: Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992, 71 (8): 599-604. 10.3109/00016349209006227.CrossRefPubMed Dahlgren E: Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992, 71 (8): 599-604. 10.3109/00016349209006227.CrossRefPubMed
14.
go back to reference Hull MG: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987, 1 (3): 235-245. 10.3109/09513598709023610.CrossRefPubMed Hull MG: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1987, 1 (3): 235-245. 10.3109/09513598709023610.CrossRefPubMed
16.
go back to reference Kahsar-Miller MD: Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001, 75 (1): 53-58. 10.1016/S0015-0282(00)01662-9.CrossRefPubMed Kahsar-Miller MD: Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001, 75 (1): 53-58. 10.1016/S0015-0282(00)01662-9.CrossRefPubMed
17.
go back to reference Coviello AD: High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metabol. 2009, 94 (11): 4361-4366. 10.1210/jc.2009-1333.CrossRef Coviello AD: High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metabol. 2009, 94 (11): 4361-4366. 10.1210/jc.2009-1333.CrossRef
18.
19.
go back to reference Reis KS: Anthropometric and metabolic evaluation of first-degree male relatives of women with polycystic ovary syndrome. Rev Bras Ginecol Obstet. 2010, 32 (7): 334-339. 10.1590/S0100-72032010000700005.CrossRefPubMed Reis KS: Anthropometric and metabolic evaluation of first-degree male relatives of women with polycystic ovary syndrome. Rev Bras Ginecol Obstet. 2010, 32 (7): 334-339. 10.1590/S0100-72032010000700005.CrossRefPubMed
20.
go back to reference Sam S: Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2005, 90 (8): 4797-4802. 10.1210/jc.2004-2217.CrossRef Sam S: Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2005, 90 (8): 4797-4802. 10.1210/jc.2004-2217.CrossRef
21.
go back to reference Sam S: Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metab Clin Exp. 2008, 57 (1): 84-89. 10.1016/j.metabol.2007.08.010.PubMedCentralCrossRefPubMed Sam S: Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metab Clin Exp. 2008, 57 (1): 84-89. 10.1016/j.metabol.2007.08.010.PubMedCentralCrossRefPubMed
22.
go back to reference Legro RS: Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998, 95 (25): 14956-14960. 10.1073/pnas.95.25.14956.PubMedCentralCrossRefPubMed Legro RS: Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1998, 95 (25): 14956-14960. 10.1073/pnas.95.25.14956.PubMedCentralCrossRefPubMed
23.
go back to reference Zawadzki JK DA: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. 1992, Oxford, UK: Blackwell, 59-69. Zawadzki JK DA: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. 1992, Oxford, UK: Blackwell, 59-69.
24.
go back to reference Kuczmarski RJ: CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2000, 2002 (246): 1-190. Kuczmarski RJ: CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2000, 2002 (246): 1-190.
25.
go back to reference Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981, 68 (6): 1456-1467. 10.1172/JCI110398.PubMedCentralCrossRefPubMed Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981, 68 (6): 1456-1467. 10.1172/JCI110398.PubMedCentralCrossRefPubMed
26.
go back to reference Matthews DR: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28 (7): 412-419. 10.1007/BF00280883.CrossRefPubMed
27.
go back to reference Katz A: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metabol. 2000, 85 (7): 2402-2410. 10.1210/jc.85.7.2402.CrossRef Katz A: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metabol. 2000, 85 (7): 2402-2410. 10.1210/jc.85.7.2402.CrossRef
28.
go back to reference Rosenbaum M: beta-Cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metabol. 2004, 89 (11): 5469-5476. 10.1210/jc.2004-0971.CrossRef Rosenbaum M: beta-Cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metabol. 2004, 89 (11): 5469-5476. 10.1210/jc.2004-0971.CrossRef
29.
go back to reference Li Z, Huang H: Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Medical hypotheses. 2008, 70 (3): 638-642. 10.1016/j.mehy.2006.09.076.CrossRefPubMed Li Z, Huang H: Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Medical hypotheses. 2008, 70 (3): 638-642. 10.1016/j.mehy.2006.09.076.CrossRefPubMed
30.
go back to reference Govind A, Obhrai MS, Clayton RN: Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metabol. 1999, 84 (1): 38-43. 10.1210/jc.84.1.38.CrossRef Govind A, Obhrai MS, Clayton RN: Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metabol. 1999, 84 (1): 38-43. 10.1210/jc.84.1.38.CrossRef
32.
go back to reference Givens JR: Familial polycystic ovarian disease. Endocrinol Metab Clin North Am. 1988, 17 (4): 771-783.PubMed Givens JR: Familial polycystic ovarian disease. Endocrinol Metab Clin North Am. 1988, 17 (4): 771-783.PubMed
33.
go back to reference Urbanek M: The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007, 3 (2): 103-111. 10.1038/ncpendmet0400.CrossRefPubMed Urbanek M: The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab. 2007, 3 (2): 103-111. 10.1038/ncpendmet0400.CrossRefPubMed
34.
go back to reference Prodoehl MJ: Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod. 2009, 15 (12): 829-841. 10.1093/molehr/gap072.PubMedCentralCrossRefPubMed Prodoehl MJ: Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod. 2009, 15 (12): 829-841. 10.1093/molehr/gap072.PubMedCentralCrossRefPubMed
35.
go back to reference Tok EC: Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype. Hum Reprod. 2005, 20 (6): 1590-1595. 10.1093/humrep/deh769.CrossRefPubMed Tok EC: Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype. Hum Reprod. 2005, 20 (6): 1590-1595. 10.1093/humrep/deh769.CrossRefPubMed
36.
go back to reference Escobar-Morreale HF: Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res. 2003, 11 (8): 987-996. 10.1038/oby.2003.136.CrossRefPubMed Escobar-Morreale HF: Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res. 2003, 11 (8): 987-996. 10.1038/oby.2003.136.CrossRefPubMed
37.
go back to reference Lenarcik A: Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynol Pol. 2011, 62 (2): 129-133.PubMed Lenarcik A: Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynol Pol. 2011, 62 (2): 129-133.PubMed
38.
go back to reference Unluhizarci K: Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome. Fertil Steril. 2007, 87 (6): 1377-1382. 10.1016/j.fertnstert.2006.11.075.CrossRefPubMed Unluhizarci K: Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome. Fertil Steril. 2007, 87 (6): 1377-1382. 10.1016/j.fertnstert.2006.11.075.CrossRefPubMed
39.
go back to reference Yildiz BO: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2003, 88 (5): 2031-2036. 10.1210/jc.2002-021499.CrossRef Yildiz BO: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2003, 88 (5): 2031-2036. 10.1210/jc.2002-021499.CrossRef
40.
go back to reference Sir-Petermann T: Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2009, 94 (6): 1923-1930. 10.1210/jc.2008-2836.CrossRef Sir-Petermann T: Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2009, 94 (6): 1923-1930. 10.1210/jc.2008-2836.CrossRef
41.
go back to reference Vigouroux C: What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?. Ann Endocrinol (Paris). 2010, 71 (3): 222-224. 10.1016/j.ando.2010.02.017.CrossRef Vigouroux C: What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?. Ann Endocrinol (Paris). 2010, 71 (3): 222-224. 10.1016/j.ando.2010.02.017.CrossRef
42.
go back to reference DiMartino-Nardi J: Insulin resistance in prepubertal African-American and Hispanic girls with premature adrenarche: a risk factor for polycystic ovary syndrome. Trends Endocrinol Metab. 1998, 9 (2): 78-82. 10.1016/S1043-2760(98)00023-X.CrossRefPubMed DiMartino-Nardi J: Insulin resistance in prepubertal African-American and Hispanic girls with premature adrenarche: a risk factor for polycystic ovary syndrome. Trends Endocrinol Metab. 1998, 9 (2): 78-82. 10.1016/S1043-2760(98)00023-X.CrossRefPubMed
43.
go back to reference Ferrannini E, Mari A: Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004, 47 (5): 943-956. 10.1007/s00125-004-1381-z.CrossRefPubMed Ferrannini E, Mari A: Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004, 47 (5): 943-956. 10.1007/s00125-004-1381-z.CrossRefPubMed
44.
go back to reference Porte D: Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes. 1991, 40 (2): 166-180. 10.2337/diabetes.40.2.166.CrossRefPubMed Porte D: Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes. 1991, 40 (2): 166-180. 10.2337/diabetes.40.2.166.CrossRefPubMed
45.
go back to reference Rosenbaum M: School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. J Clin Endocrinol Metabol. 2007, 92 (2): 504-508.CrossRef Rosenbaum M: School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. J Clin Endocrinol Metabol. 2007, 92 (2): 504-508.CrossRef
46.
go back to reference Bergman RN: Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002, 51 (Suppl 1): S212-S220.CrossRefPubMed Bergman RN: Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002, 51 (Suppl 1): S212-S220.CrossRefPubMed
Metadata
Title
Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome
Authors
Nouhad Raissouni
Andrey Kolesnikov
Radhika Purushothaman
Sunil Sinha
Sonal Bhandari
Amrit Bhangoo
Shahid Malik
Revi Mathew
Jean-Patrice Baillargeon
Maria Isabel Hernandez
Michael Rosenbaum
Svetlana Ten
David Geller
Publication date
01-12-2012
Publisher
BioMed Central
Published in
International Journal of Pediatric Endocrinology / Issue 1/2012
Electronic ISSN: 1687-9856
DOI
https://doi.org/10.1186/1687-9856-2012-14

Other articles of this Issue 1/2012

International Journal of Pediatric Endocrinology 1/2012 Go to the issue